Overview

Methods in Molecular Biology

Volumn 1100, Issue , 2014, Pages 1-9

  Gadjeva, Mihaela ^a  

^a HARVARD UNIVERSITY   (United States)

Author keywords

Complement; Innate immunity

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C4A; COMPLEMENT FACTOR D; COMPLEMENT MEMBRANE ATTACK COMPLEX; FICOLIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LECTIN; MANNOSE; PROPERDIN; SERINE PROTEINASE;

ANTIGEN ANTIBODY COMPLEX; COMPLEMENT ACTIVATION; COMPLEMENT DEFICIENCY; COMPLEMENT DEPOSITION; COMPLEMENT SYSTEM; CONFORMATIONAL TRANSITION; ENZYME ACTIVITY; ENZYME SPECIFICITY; HUMAN; INNATE IMMUNITY; MEDICAL RESEARCH; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; SHEEP ERYTHROCYTE; TISSUE REGENERATION;

EID: 84934434949     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-724-2_1     Document Type: Review

References (50)

1. Carroll MV, Sim RB (2011) Complement in health and disease. Adv Drug Deliv Rev 63:965-975
2. Reid KB, Day AJ (1990) Ig-binding domains of C1q. Immunol Today 11:387-388
3. Reid KB (1989) Chemistry and molecular genetics of C1q. Behring Inst Mitt 84:8-19
4. Reid KB, Lowe DM, Porter RR (1972) Isolation and characterization of C1q, a subcomponent of the first component of complement, from human and rabbit sera. Biochem J 130:749-763
5. Gaboriaud C, Thielens NM, Gregory LA, Rossi V, Fontecilla-Camps JC, Arlaud GJ (2004) Structure and activation of the C1 complex of complement: unraveling the puzzle. Trends Immunol 25:368-373
6. Cooper NR (1985) The classical complement pathway: activation and regulation of the first complement component. Adv Immunol 37:151-216
7. Gadjeva M, Dodds AW, Taniguchi-Sidle A, Willis AC, Isenman DE, Law SK (1998) The covalent binding reaction of complement component C3. J Immunol 161:985-990
8. Law SK, Dodds AW (1996) Catalysed hydrolysis: the complement quickstep. Immunol Today 17:105
9. Gotze O, Muller-Eberhard HJ (1974) The role of properdin in the alternate pathway of complement activation. J Exp Med 139:44-57
10. Goundis D, Reid KB (1988) Properdin, the terminal complement components, thrombospondin and the circumsporozoite protein of malaria parasites contain similar sequence motifs. Nature 335:82-85
11. Thiel S, Vorup-Jensen T, Stover CM, Schwaeble W, Laursen SB, Poulsen K, Willis AC, Eggleton P, Hansen S, Holmskov U, Reid KB, Jensenius JC (1997) A second serine protease associated with mannan-binding lectin that activates complement. Nature 386:506-510
12. Thiel S, Jensen L, Degn SE, Nielsen HJ, Gal P, Dobo J, Jensenius JC (2012) Mannan-binding lectin (MBL)-associated serine protease-1 (MASP-1), a serine protease associated with humoral pattern-recognition molecules: normal and acute-phase levels in serum and stoichiometry of lectin pathway components. Clin Exp Immunol 169:38-48
13. Sekine H, Takahashi M, Iwaki D, Fujita T (2013) The role of MASP-1/3 in complement activation. Adv Exp Med Biol 734:41-53
14. Selman L, Hansen S (2012) Structure and function of collectin liver 1 (CL-L1) and collectin 11 (CL-11, CL-K1). Immunobiology 217:851-863
15. Kolb WP, Muller-Eberhard HJ (1974) Mode of action of human C9: adsorption of multiple C9 molecules to cell-bound C8. J Immunol 113:479-488
16. Whaley K, Ruddy S (1976) Modulation of C3b hemolytic activity by a plasma protein distinct from C3b inactivator. Science 193:1011-1013
17. Dempsey PW, Allison ME, Akkaraju S, Goodnow CC, Fearon DT (1996) C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 271:348-350
18. Carroll MC, Isenman DE (2012) Regulation of humoral immunity by complement. Immunity 37:199-207
19. van den Elsen JM, Isenman DE (2011) A crystal structure of the complex between human complement receptor 2 and its ligand C3d. Science 332:608-611
20. Khan DA (2011) Hereditary angioedema: historical aspects, classification, pathophysiology, clinical presentation, and laboratory diagnosis. Allergy Asthma Proc 32:1-10
21. Nilsson UR, Nilsson B (1984) Simplified assays of hemolytic activity of the classical and alternative complement pathways. J Immunol Methods 72:49-59
22. Joiner KA, Hawiger A, Gelfand JA (1983) A study of optimal reaction conditions for an assay of the human alternative complement pathway. Am J Clin Pathol 79:65-72
23. Seelen MA, Roos A, Wieslander J, Mollnes TE, Sjoholm AG, Wurzner R, Loos M, Tedesco F, Sim RB, Garred P, Alexopoulos E, Turner MW, Daha MR (2005) Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA. J Immunol Methods 296:187-198
24. Sjoholm AG, Selander B, Ostenson S, Holmstrom E, Soderstrom C (1991) Normal human serum depleted of C1q, factor D and properdin: its use in studies of complement activation. APMIS 99:1120-1128
25. Petersen SV, Thiel S, Jensenius JC (2001) The mannan-binding lectin pathway of complement activation: biology and disease association. Mol Immunol 38:133-149
26. Majewski J, Schultz DW, Weleber RG, Schain MB, Edwards AO, Matise TC, Acott TS, Ott J, Klein ML (2003) Age-related macular degeneration: a genome scan in extended families. Am J Hum Genet 73:540-550
27. Warwicker P, Goodship TH, Donne RL, Pirson Y, Nicholls A, Ward RM, Turnpenny P, Goodship JA (1998) Genetic studies into inherited and sporadic hemolytic uremic syndrome. Kidney Int 53:836-844
28. Truedsson L, Bengtsson AA, Sturfelt G (2007) Complement deficiencies and systemic lupus erythematosus. Autoimmunity 40:560-566
29. Trendelenburg M (2005) Antibodies against C1q in patients with systemic lupus erythematosus. Springer Semin Immunopathol 27:276-285
30. Manderson AP, Botto M, Walport MJ (2004) The role of complement in the development of systemic lupus erythematosus. Annu Rev Immunol 22:431-456
31. Yang Y, Chung EK, Zhou B, Lhotta K, Hebert LA, Birmingham DJ, Rovin BH, Yu CY (2004) The intricate role of complement component C4 in human systemic lupus erythematosus. Curr Dir Autoimmun 7:98-132
32. Carroll MC (2004) The complement system in B cell regulation. Mol Immunol 41:141-146
33. Garred P, Larsen F, Seyfarth J, Fujita R, Madsen HO (2006) Mannose-binding lectin and its genetic variants. Genes Immun 7:85-94
34. Heitzeneder S, Seidel M, Forster-Waldl E, Heitger A (2012) Mannan-binding lectin deficiency: good news, bad news, doesn't matter? Clin Immunol 143:22-38
35. Thiel S, Gadjeva M (2009) Humoral pattern recognition molecules: mannan-binding lectin and ficolins. Adv Exp Med Biol 653:58-73
36. Super M, Thiel S, Lu J, Levinsky RJ, Turner MW (1989) Association of low levels of mannan-binding protein with a common defect of opsonisation. Lancet 2:1236-1239
37. Thiel S, Frederiksen PD, Jensenius JC (2006) Clinical manifestations of mannan-binding lectin deficiency. Mol Immunol 43:86-96
38. Garred P, Pressler T, Lanng S, Madsen HO, Moser C, Laursen I, Balstrup F, Koch C, Koch C (2002) Mannose-binding lectin (MBL) therapy in an MBL-deficient patient with severe cystic fibrosis lung disease. Pediatr Pulmonol 33:201-207
39. Hillmen P, Hall C, Marsh JC, Elebute M, Bombara MP, Petro BE, Cullen MJ, Richards SJ, Rollins SA, Mojcik CF, Rother RP (2004) Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria. N Engl J Med 350:552-559
40. Michalski M, Szala A, St Swierzko A, Lukasiewicz J, Maciejewska A, Kilpatrick DC, Matsushita M, Domzalska-Popadiuk I, Borkowska-Klos M, Sokolowska A, Szczapa J, Lugowski C, Cedzynski M (2012) H-ficolin (ficolin-3) concentrations and FCN3 gene polymorphism in neonates. Immunobiology 217:730-737
41. Cedzynski M, Atkinson AP, St Swierzko A, MacDonald SL, Szala A, Zeman K, Buczylko K, Bak-Romaniszyn L, Wiszniewska M, Matsushita M, Szemraj J, Banasik M, Turner ML, Kilpatrick DC (2009) L-ficolin (ficolin-2) insufficiency is associated with combined allergic and infectious respiratory disease in children. Mol Immunol 47:415-419
42. Terai I, Kobayashi K, Matsushita M, Fujita T (1997) Human serum mannose-binding lectin (MBL)-associated serine protease-1 (MASP- 1): determination of levels in body fluids and identification of two forms in serum. Clin Exp Immunol 110:317-323
43. Moller-Kristensen M, Jensenius JC, Jensen L, Thielens N, Rossi V, Arlaud G, Thiel S (2003) Levels of mannan-binding lectin-associated serine protease-2 in healthy individuals. J Immunol Methods 282:159-167
44. Degn SE, Jensen L, Gal P, Dobo J, Holmvad SH, Jensenius JC, Thiel S (2010) Biological variations of MASP-3 and MAp44, two splice products of the MASP1 gene involved in regulation of the complement system. J Immunol Methods 361:37-50
45. Degn SE, Thiel S, Nielsen O, Hansen AG, Steffensen R, Jensenius JC (2011) MAp19, the alternative splice product of the MASP2 gene. J Immunol Methods 373:89-101
46. Oglesby TJ, Ueda A, Volanakis JE (1988) Radioassays for quantitation of intact complement proteins C2 and B in human serum. J Immunol Methods 110:55-62
47. Hiemstra PS, Langeler E, Compier B, Keepers Y, Leijh PC, van den Barselaar MT, Overbosch D, Daha MR (1989) Complete and partial deficiencies of complement factor D in a Dutch family. J Clin Invest 84:1957-1961
48. de Paula PF, Barbosa JE, Junior PR, Ferriani VP, Latorre MR, Nudelman V, Isaac L (2003) Ontogeny of complement regulatory proteins - concentrations of factor h, factor I, c4b binding protein, properdin and vitronectin in healthy children of different ages and in adults. Scand J Immunol 58:572-577
49. Sofat R, Mangione PP, Gallimore JR, Hakobyan S, Hughes TR, Shah T, Goodship T, D'Aiuto F, Langenberg C, Wareham N, Morgan BP, Pepys MB, Hingorani AD (2013) Distribution and determinants of circulating complement factor H concentration determined by a high-throughput immunonephelometric assay. J Immunol Methods 390:63-73
50. Tan LA, Yu B, Sim FC, Kishore U, Sim RB (2010) Complement activation by phospholipids: the interplay of factor H and C1q. Protein Cell 1:1033-1049